2022
DOI: 10.1021/acsami.1c19192
|View full text |Cite
|
Sign up to set email alerts
|

Polycationic HA/CpG Nanoparticles Induce Cross-Protective Influenza Immunity in Mice

Abstract: The intranasal (i.n.) route is an ideal vaccination approach for infectious respiratory diseases like influenza. Polycationic polyethylenimine (PEI) could form nanoscale complexes with negatively charged viral glycoproteins. Here we fabricated PEI-hemagglutinin (HA) and PEI-HA/CpG nanoparticles and investigated their immune responses and protective efficacies with an i.n. vaccination regimen in mice. Our results revealed that the nanoparticles significantly enhanced HA immunogenicity, providing heterologous cr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
16
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 17 publications
(16 citation statements)
references
References 53 publications
0
16
0
Order By: Relevance
“…A sustained release profile accounting for approximately 20% drug release at 2 h indicated that the drugs were released slowly from the liposomal DPI in the lungs, thus could offer the opportunity to reduce the need of frequent dosing [ 76 ]. In addition, various nanoparticle-based strategies have been designed to tackle influenza infection, including the use of a nanoparticle as carrier of the vaccine, genes and drugs [ 5 , 77 80 ]. In addition, nanoparticles with anti-influenza properties are also under development [ 79 , 81 ] (Fig.…”
Section: Inhalation Nanotherapies For Viral Respiratory Infectionsmentioning
confidence: 99%
See 3 more Smart Citations
“…A sustained release profile accounting for approximately 20% drug release at 2 h indicated that the drugs were released slowly from the liposomal DPI in the lungs, thus could offer the opportunity to reduce the need of frequent dosing [ 76 ]. In addition, various nanoparticle-based strategies have been designed to tackle influenza infection, including the use of a nanoparticle as carrier of the vaccine, genes and drugs [ 5 , 77 80 ]. In addition, nanoparticles with anti-influenza properties are also under development [ 79 , 81 ] (Fig.…”
Section: Inhalation Nanotherapies For Viral Respiratory Infectionsmentioning
confidence: 99%
“…Notably, owing to a lack of IFN-γ cytokine induction, the protective cellular responses such as cytotoxic T-lymphocyte activation are not induced with PEI. Therefore, the incorporation of unmethylated cytosine-guanine rich oligonucleotide motifs (CpG) onto PEI-HA might trigger the TLR-9 signalling pathway, thus inducing a balanced Th1/Th2 immune response [ 77 ]. Compared to the PEI-HA nanoparticle, the intranasal vaccination of PEI-HA/CpG nanoparticles led to a more balanced Th1/Th2 response with the generation of an IgG1 and IgG2a antibody as well as enhanced neutralising action and Fc-mediated antibody-dependent cellular cytotoxicity (ADCC) [ 77 ].…”
Section: Inhalation Nanotherapies For Viral Respiratory Infectionsmentioning
confidence: 99%
See 2 more Smart Citations
“…Independent studies by Kobiyama et al and Nishikawa et al have shown that nanoparticulation of CpG ODNs enhances dramatically their immunostimulatory activity. In addition, many other studies have demonstrated nanoparticulated CpG ODNs, indicating the rising interest in incorporating CpG ODNs into nanoparticles.…”
Section: Introductionmentioning
confidence: 99%